Education
About Us
Working with TipRanks
Follow Us
Senores Pharmaceuticals Ltd. (IN:SENORES)
:SENORES
SENORES Stock Chart & Stats
₹716.90
--
Market closed
₹716.90
--
Day’s Range― - ―
52-Week Range₹440.00 - ₹847.90
Previous CloseN/A
VolumeN/A
Average Volume (3M)11.47K
Market Cap
₹37.48B
Enterprise Value₹32.25B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)43.0
Beta1.01
Next Earnings
Jan 22, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)7.00
Shares Outstanding46,053,590
10 Day Avg. Volume13,254
30 Day Avg. Volume11,469
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1,906.36
Revenue Forecast (FY)₹535.30B
Senores Pharmaceuticals Ltd. News
SENORES FAQ
What was Senores Pharmaceuticals Ltd.’s price range in the past 12 months?
Senores Pharmaceuticals Ltd. lowest stock price was ₹440.00 and its highest was ₹847.90 in the past 12 months.
What is Senores Pharmaceuticals Ltd.’s market cap?
Senores Pharmaceuticals Ltd.’s market cap is ₹37.48B.
When is Senores Pharmaceuticals Ltd.’s upcoming earnings report date?
Senores Pharmaceuticals Ltd.’s upcoming earnings report date is Jan 22, 2026 which is in 24 days.
How were Senores Pharmaceuticals Ltd.’s earnings last quarter?
Senores Pharmaceuticals Ltd. released its earnings results on Nov 06, 2025. The company reported ₹7 earnings per share for the quarter, beating the consensus estimate of N/A by ₹7.
Is Senores Pharmaceuticals Ltd. overvalued?
According to Wall Street analysts Senores Pharmaceuticals Ltd.’s price is currently Overvalued.
Does Senores Pharmaceuticals Ltd. pay dividends?
Senores Pharmaceuticals Ltd. does not currently pay dividends.
What is Senores Pharmaceuticals Ltd.’s EPS estimate?
Senores Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Senores Pharmaceuticals Ltd. have?
Senores Pharmaceuticals Ltd. has 46,053,590 shares outstanding.
What happened to Senores Pharmaceuticals Ltd.’s price movement after its last earnings report?
Senores Pharmaceuticals Ltd. reported an EPS of ₹7 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.086%.
Which hedge fund is a major shareholder of Senores Pharmaceuticals Ltd.?
Currently, no hedge funds are holding shares in IN:SENORES
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Senores Pharmaceuticals Ltd.
Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics, as well as management and consultancy services. The company was incorporated in 2017 and is based in Ahmedabad, India.
Technical Analysis
Balaxi Pharmaceuticals Limited
―
Bal Pharma Limited
―
Biofil Chemicals & Pharmaceuticals Ltd.
―
Lasa Supergenerics Ltd.
―
Sakar Healthcare Ltd
―